Found: 23
Select item for more details and to access through your institution.
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 4, p. 1227, doi. 10.1007/s00432-020-03413-5
- By:
- Publication type:
- Article
Secondary EML4–ALK-positive Lung Adenocarcinoma in a Patient Previously Treated for Acute Lymphoblastic Leukemia in Childhood: A Case Report.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 6, p. 593, doi. 10.1093/jjco/hyu028
- By:
- Publication type:
- Article
Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 5, p. 521, doi. 10.1016/j.cllc.2013.04.005
- By:
- Publication type:
- Article
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 61, n. 2, p. 93, doi. 10.1159/000441486
- By:
- Publication type:
- Article
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2890, doi. 10.1111/1759-7714.15097
- By:
- Publication type:
- Article
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 16, p. 2404, doi. 10.1111/1759-7714.14555
- By:
- Publication type:
- Article
Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 13, p. 1983, doi. 10.1111/1759-7714.14001
- By:
- Publication type:
- Article
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 1972, doi. 10.1111/1759-7714.13490
- By:
- Publication type:
- Article
Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 389, doi. 10.1111/1759-7714.13279
- By:
- Publication type:
- Article
Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 9, p. 1764, doi. 10.1111/1759-7714.13134
- By:
- Publication type:
- Article
Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 452, doi. 10.1111/1759-7714.12958
- By:
- Publication type:
- Article
Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 11, p. 1522, doi. 10.1111/1759-7714.12872
- By:
- Publication type:
- Article
Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 1, p. 51, doi. 10.1111/1759-7714.12535
- By:
- Publication type:
- Article
Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 6, p. 577, doi. 10.1111/1759-7714.12483
- By:
- Publication type:
- Article
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4
- By:
- Publication type:
- Article
Phase II trial of erlotinib in patients with advanced nonsmallcell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1299, doi. 10.1007/s00280-013-2307-6
- By:
- Publication type:
- Article
Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 645, doi. 10.1007/s00280-012-1952-5
- By:
- Publication type:
- Article
Fundamental Aspects of Wire Arc Additive Manufacturing for Aluminum Foams.
- Published in:
- Materials Transactions, 2024, v. 65, n. 6, p. 672, doi. 10.2320/matertrans.MT-M2024006
- By:
- Publication type:
- Article
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 3211, doi. 10.2147/OTT.S136837
- By:
- Publication type:
- Article
Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight.
- Published in:
- Cancer Science, 2023, v. 114, n. 5, p. 2087, doi. 10.1111/cas.15736
- By:
- Publication type:
- Article